Acquired perforating dermatosis. Treatment with allopurinol

Authors

  • Helberth José Cuchía
  • Andrea del Pilar Salamanca
  • Elkin Peñaranda

Keywords:

Dermatoses, therapy, allopurinol

Abstract

Perforating diseases include a variety of dermatoses characterized by the presence of transepidermal elimination. There are four classic perforating disorders and in the last years, the concept of acquired perforating dermatosis was introduced for any classic perforating dermatosis in association with diabetes and/or renal failure. We reported a case of acquired perforating dermatosis which showed clinical improvement after treatment with allopurinol.

Author Biographies

Helberth José Cuchía

Médico, residente de segundo año de Dermatología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia

Andrea del Pilar Salamanca

Médica, residente de tercer año de Dermatología, Facultad de medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia.

Elkin Peñaranda

Médico dermatólogo oncólogo, Hospital Universitario de La Samaritana; docente, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombiacatedrático, Facultad de Medicina, Universidad de La Sabana, Chía, Cundinamarca.

References

1. Otero M, Gómez ML, Cabrera HN, García S. Colagenosis perforante reactiva. Tratamiento con alopurinol. Act Terap Dermatol. 2007;30:246-9.
2. Arias M, La Forgia M, Buonsante ME, Portaluppi M, Kien MC, Pellerano G. Dermatosis perforante adquirida en pacientes con insuficiencia renal crónica. Comunicación de tres casos y revisión de la literatura. Dermatol Argent. 2007;13:184-9.
3. Arredondo MI, Londoño A, Restrepo R. Enfermedades con eliminación transepidérmica. Rev Asoc Col Dermatol. 2008;16:185-95.
4. Saray Y, Seckin D, Bilezikci B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol. 2006;20:679-88.
5. Yancovitz M, Johnson H, Wang N, Pomeranz MK. Perforating collagenosis. Dermatol Online J. 2008;14:14.
6. Tsuboi H, Katsuoka K. Characteristics of acquired reactive perforating collagenosis. J Dermatol. 2007;34:640-4.
7. Hoque SR, Ameen M, Holden CA. Acquired reactive perforating collagenosis: four patients with a giant variant treated with allopurinol. Br J Dermatol. 2006;154:759-62.
8. Iyoda M, Hayashi F, Kuroki A, Shibata T, Kitazawa K, Sugisaki T, et al. Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol. Am J Kidney Dis. 2003;42:E11-3.

How to Cite

1.
Cuchía HJ, Salamanca A del P, Peñaranda E. Acquired perforating dermatosis. Treatment with allopurinol. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 12 [cited 2024 Jul. 3];17(2):134-7. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/162

Downloads

Download data is not yet available.

Published

2019-02-12

How to Cite

1.
Cuchía HJ, Salamanca A del P, Peñaranda E. Acquired perforating dermatosis. Treatment with allopurinol. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 12 [cited 2024 Jul. 3];17(2):134-7. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/162

Issue

Section

Case Report
QR Code
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views